Cardiology
Cardiovascular effects of cancer therapy
Also called onco-cardiology, cancer cardiotoxicity, chemotherapy heart
Sources: updated Oct 10, 2026
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does anticoagulants vs placebo improve outcomes in Malignant Neoplasms?
Low CertaintySupports benefitanticoagulants vs placebo · Myocardial Infarction Hospitalization
Does sodium-glucose cotransporter-2 inhibitors vs immune checkpoint inhibitors improve All-Cause Mortality in Malignant Neoplasms?
Low Certaintysodium-glucose cotransporter-2 inhibitors vs Immune checkpoint inhibitors · All-Cause Mortality
Synthesized from 9 evidence-backed clinical questions on Cardio-oncology — 5 supports benefit, 4 no benefit shown.
The placed evidence leans toward benefit
5
Favor benefit
56% of all
4
No benefit shown
44% of all
Low certainty on 100% of questions
Does aspirin vs placebo improve outcomes in Malignant Neoplasms?
Low Certainty+ Favors benefitaspirin vs placebo · All-Cause Mortality
10 studies (3,518,238 patients) provide low-certainty evidence for benefit of aspirin for All-Cause Mortality in Malignant Neoplasms.
Does sglt2 inhibitors vs placebo improve All-Cause Mortality in Malignant Neoplasms?
Low Certainty+ Favors benefitsglt2 inhibitors vs placebo · All-Cause Mortality
4 studies (263,352 patients) provide low-certainty evidence for benefit of sglt2 inhibitors for All-Cause Mortality in Malignant Neoplasms.
A clinical question appears here only when its condition matches this topic, an outcome and a comparator were extracted from the studies, at least two studies and a patient count are on file, and the certainty is low or higher.
Supports benefit, no benefit shown, and mixed describe the direction of the measured effect. No benefit shown means the evidence does not support a benefit. It is not a finding of harm. Too little evidence means the question did not clear that bar.
Study count, RCT count, and patient count are separate. The patient total adds only studies that are linked into a study family and whose sample size is not flagged as implausible. A reversal is listed only when at least one randomized trial sits on each side of the change.
The overview is drafted from the guideline recommendations, trials, papers, and questions on this page, and every sentence has to cite one of them. It stays unverified until an NPI-verified clinician or a Synapse admin approves it. Approving records that person's name.